Overview
Ludmila Lamparska-Zajac practices practicing medicine in Bydgoszcz, Poland.
Her clinical expertise encompasses Developmental Dysphasia Familial and Hodgkin Lymphoma.
She is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ludmila Lamparska-Zajac
Is Ludmila Lamparska-Zajac a top-rated expert for Developmental Dysphasia Familial?
MediFind is an objective health platform that identifies experts based on real-world data. Ludmila Lamparska-Zajac is classified as an Experienced expert for Developmental Dysphasia Familial, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ludmila Lamparska-Zajac participate in research or clinical trials?
Yes. Ludmila Lamparska-Zajac has published 13 articles and abstracts on conditions like Developmental Dysphasia Familial. You can view a list of Ludmila Lamparska-Zajac's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Developmental Dysphasia FamilialMs. Lamparska-Zajac isExperienced. Learn about Developmental Dysphasia Familial.
- Hodgkin LymphomaMs. Lamparska-Zajac isExperienced. Learn about Hodgkin Lymphoma.